Zepad 7.5mg/0.5mL Injection (Tirzepatide) – 1 Injection

KSh8,000.00

Zepad 7.5mg/0.5mL Injection contains tirzepatide, a dual GIP and GLP-1 receptor agonist used in the management of type 2 diabetes. Supplied as a pre-filled syringe with a disposable autoinjector for subcutaneous administration, this strength may be prescribed when additional glycaemic control is required. Available at ePharmacy Kenya with prescription verification and delivery in Nairobi and across Kenya.

SKU: ZEP75 Category:

Description

Zepad 7.5mg/0.5mL Injection is a prescription medicine containing tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.

It is used alongside diet and exercise to improve glycaemic control in people with type 2 diabetes mellitus.

Tirzepatide works through two incretin hormone pathways involved in blood glucose regulation. It enhances glucose-dependent insulin secretion, reduces glucagon secretion and delays gastric emptying.

Key Product Features

  • Brand: Zepad
  • Active ingredient: Tirzepatide
  • Strength: 7.5mg/0.5mL
  • Dosage form: Solution for injection
  • Administration: Subcutaneous injection
  • Presentation: Pre-filled syringe with disposable autoinjector
  • Therapeutic class: Antidiabetic medicine

Indications

Zepad is indicated as an adjunct to diet and exercise to improve blood glucose control in patients with type 2 diabetes mellitus.

The 7.5mg strength may be prescribed as part of an individualised treatment plan when a healthcare professional determines that a dose increase is appropriate.

How Does Zepad Work?

The active ingredient, tirzepatide, activates GIP and GLP-1 receptors.

This dual action helps:

  • Improve insulin secretion when blood glucose levels are elevated.
  • Reduce glucagon secretion.
  • Slow gastric emptying.
  • Support better blood glucose regulation.

Dosage and Administration

Tirzepatide treatment generally starts at 2.5mg once weekly for four weeks, followed by 5mg once weekly.

If additional glycaemic control is needed, the prescribing clinician may increase the dose in 2.5mg increments after at least four weeks on the current dose.

Zepad 7.5mg/0.5mL is one of the available dose strengths. It should only be used when specifically prescribed by a qualified healthcare professional.

Administer by subcutaneous injection according to the product instructions. Do not increase or change your dose independently.

Possible Side Effects

Commonly reported side effects include:

  • Nausea
  • Vomiting
  • Diarrhoea
  • Constipation
  • Reduced appetite
  • Abdominal discomfort

Serious but less common risks include pancreatitis, gallbladder problems, severe gastrointestinal reactions, dehydration-related kidney injury and serious hypersensitivity reactions.

Seek immediate medical attention if you develop severe persistent abdominal pain or signs of a serious allergic reaction.

Important Precautions

Tell your doctor or pharmacist before using Zepad if you:

  • Have a history of pancreatitis.
  • Have gallbladder or significant gastrointestinal disease.
  • Take insulin or sulphonylurea medication.
  • Have a history of serious allergic reactions to tirzepatide.
  • Are pregnant, breastfeeding or planning to become pregnant.

Always follow your prescribed treatment schedule and attend recommended medical reviews.

Buy Zepad 7.5mg Injection in Kenya

Looking for Zepad 7.5mg/0.5mL Injection in Kenya? Purchase through ePharmacy Kenya, your online pharmacy for prescription medicines and healthcare products.

We provide convenient online ordering for customers in Nairobi and other parts of Kenya, subject to delivery availability.

Prescription Required: This is a prescription-only medicine. A valid prescription must be submitted and verified before dispensing.

Do not use without medical supervision. Read the product leaflet and follow your healthcare professional’s instructions.

Reviews

There are no reviews yet.

Be the first to review “Zepad 7.5mg/0.5mL Injection (Tirzepatide) – 1 Injection”